Concepedia
Statistics
Publications
9
Citations
867
H-Index
Active since
2016
Affiliations
Almac (United Kingdom)(Current)
Queen's University Belfast
Belfast Health and Social Care Trust
Edinburgh Cancer Research
Belfast City Hospital
Laura A. Knight is an author at Almac (United Kingdom) specializing in molecular oncology, medicine, and oncology.
Publications per year
2016–2024
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
Eileen E. Parkes, Steven M. Walker, Laura E. Taggart et al. · JNCI Journal of the National Cancer Institute · 2016 · 460 citations · Full text
Medicine, Immunology, Oncology +17
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
Suneil Jain, C. Lyons, Steven M. Walker et al. · Annals of Oncology · 2017 · 133 citations · Full text
Medicine, Oncology, Urology +17
Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis
Shannon Telesco, Carrie Brodmerkel, Hongyan Zhang et al. · Gastroenterology · 2018 · 72 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +17
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial
Priyanka Sharma, William E. Barlow, Andrew K. Godwin et al. · Journal of Clinical Oncology · 2019 · 49 citations · Full text
Medicine, Immunology, Oncology +14
High <i>EMSY</i> expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
Robert L. Hollis, Michael Churchman, Caroline O. Michie et al. · Cancer · 2019 · 41 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 9